About Amifostine
            
            Class: | Cytoprotective agent  
Use: | Amifostine is used to reduce the risk of xerostomia (dry mouth) in patients undergoing radiation therapy for head and neck cancer and to prevent nephrotoxicity associated with cisplatin chemotherapy.  
Adult dose: | The typical adult dose for xerostomia is 200 mg/m² administered subcutaneously 30 minutes prior to radiation therapy. For nephroprotection during cisplatin therapy, the dose is 910 mg/m² administered intravenously over 15 minutes prior to cispla
         
        
            
                
                
                    
                        Drug Class
                    
                    Cytoprotective agent
                 
                
                
                    
                        Uses & Indications
                    
                    Amifostine is used to reduce the risk of xerostomia (dry mouth) in patients undergoing radiation therapy for head and neck cancer and to prevent nephrotoxicity associated with cisplatin chemotherapy.
                 
                
                
                    
                        Storage Requirements
                    
                    Store the reconstituted solution at room temperature and use within 24 hours. Unreconstituted powder should be stored at room temperature, away from moisture and light.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: MedImmune Pharma BV, NETHERLANDS
                    
                    
                    Package Size
                    1 Vial (Lyophilisate)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 1020.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        The typical adult dose for xerostomia is 200 mg/m² administered subcutaneously 30 minutes prior to radiation therapy. For nephroprotection during cisplatin therapy, the dose is 910 mg/m² administered intravenously over 15 minutes prior to cisplatin administration.
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy in pediatric patients have not been established; therefore, specific pediatric dosing is not available.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include hypotension, nausea, vomiting, flushing, and dizziness.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Contraindicated in patients with a known hypersensitivity to amifostine or any of its components, and in patients with severe renal impairment.
         
        
        
            
                Important Warnings
            
            Use with caution in patients with hypotension, dehydration, or those receiving antihypertensive medications. Monitor blood pressure closely during administration.
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.